Pro PG receives S19 A for Bleomycin Injection (market shortage Australia) - stock available now.


​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Bleomycin Injection until January 31st 2020.

Bleomycin Injection is currently experiencing a shortage of supply in Australia.

Product: Bleomycin Injection 15 Units S19a

Stock availability: Stock is available now at Wholesalers Nationally.

Ordering

Orders can be placed via Wholesalers Symbion and Central Healthcare Services (CHS) via the below PDE numbers.

Symbion PDE: 629103

CHS PDE: BLEI15PR

http://www.pbs.gov.au/info/news/2019/05/pbs-summary-of-changes-1-june-2019

Please click for Dear Health Care Professional Letter

Please click to see Product Information for Health Professionals

Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

Pro PG and Logo are registered trademarks owned by Pro Pharmaceuticals Group